About

Elijah Nazarzadeh, PhD, is the Chief Executive Officer of Acu-Flow Limited (trading as Nebu~Flow). In this role, he is responsible for business and technical developments. During his career, he has provided scientific consultation services to a number of companies in the field of emulsions and multiphase systems. Since 2015, he has worked as a postdoctoral researcher at the University of Glasgow (UK), where he developed the Nebu~Flow technology and led the commercialisation activities, founding Acu-Flow Limited in 2019. Dr Nazarzadeh received a Lee Lucas Award from the Institute of Physics (UK) for his exceptional efforts in development of Nebu~Flow® technology. He has a PhD in Fluid Mechanics from King’s College London (UK).

Contributions

EARLY INSIGHT

CREATING A PLATFORM FOR NEBULISATION OF A WIDE RANGE OF DRUG TYPES AND FORMULATIONS

Elijah Nazarzadeh and John Pritchard introduce Nebu~Flow – a novel class of nebuliser technology that represents a major step in the ability to deliver drugs efficiently to the lungs. overcoming the limitations of current systems and unlocking the potential of the inhalation route, including for systemic delivery.